ArabFinance: Macro Group Pharmaceutical (Macro Capital) (MCRO) is planning to complete acquisition transactions of companies operating within the sector of pharmaceuticals and dietary supplements in 2022, Al Mal News reported, citing Macro Group’s Chairman Ahmed El-Nayeb.
The group is currently considering a number of investment opportunities, El-Nayeb said, adding that it does not target a specific number of acquisition deals.
Moreover, he noted that the group has the necessary cash to finance all the targeted deals.
Regarding expansions, El-Nayeb pointed out that the group does not plan for any new expansions in terms of the owned factories.
Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.